Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 09, 2021

SELL
$47.16 - $54.44 $313,519 - $361,917
-6,648 Closed
0 $0
Q4 2020

Jan 14, 2021

SELL
$48.52 - $58.02 $85,928 - $102,753
-1,771 Reduced 21.04%
6,648 $332,000
Q2 2020

Jul 10, 2020

BUY
$43.1 - $55.31 $362,858 - $465,654
8,419 New
8,419 $445,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $218B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Fulton Breakefield Broenniman LLC Portfolio

Follow Fulton Breakefield Broenniman LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.